|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock based compensation | |||||
| Loss on disposal of property, plant and equipment | |||||
| Loss on dissolution of Subsidiary | |||||
| Non-cash lease expense | |||||
| Warrant Inducement Expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and other current liabilities | |||||
| Deferred revenue | |||||
| Due to related parties | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units | |||||
| Gross proceeds from the issuance of common stock and pre-funded warrants | |||||
| Payments for offering costs related to equity issuance | |||||
| Proceeds from exercise of warrants – standard terms | |||||
| Proceeds from exercise of warrants – induced terms | |||||
| Commission paid related to warrant inducement | |||||
| Legal fees paid related to warrant inducement | |||||
| Payments for deferred offering costs related to future equity issuance | |||||
| Net cash provided by financing activities | |||||
| Effect of Exchange Rate on Changes on Cash | |||||
| Net (decrease) increase in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents restricted cash at beginning of year | |||||
| Cash and restricted cash | |||||
| Supplemental information of non-cash investing and financing activities: | |||||
| Initial recognition of right-of-use lease asset and lease liability | |||||
| Issuance of shares under vested restricted stock units, net stock option exercises and unvested share issuance for services | |||||
| Disposal of fully depreciated property | |||||
| Reversal of accrued commission liability (see Note 6) | |||||
| Warrant modification costs | |||||
| Deferred offering costs not yet paid | |||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...